A novel HLA-DR alpha 1-MOG-35-55 construct treats experimental stroke
A novel HLA-DR alpha 1-MOG-35-55 construct treats experimental stroke
About this item
Full title
A novel HLA-DR alpha 1-MOG-35-55 construct treats experimental stroke
Author / Creator
Journal title
Metabolic brain disease, 2014-03, Vol.29 (1), p.37-45
Language
English
Formats
More information
Scope and Contents
Contents
Chemoattraction of leukocytes into the brain after induction of middle cerebral artery occlusion (MCAO) increases the lesion size and worsens disease outcome. Our previous studies demonstrated that partial MHC class I delta constructs can reverse this process. However, the potential application of pMHC to human stroke is limited by the need to rapi...
Alternative Titles
Full title
A novel HLA-DR alpha 1-MOG-35-55 construct treats experimental stroke
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1505348240
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1505348240
Other Identifiers
ISSN
0885-7490
E-ISSN
1573-7365
DOI
10.1007/s11011-013-9440-0
How to access this item
Log in as a Library member
